Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

The cancer anorexia/weight loss syndrome occurs in over 80% of patients with incurable cancer and is associated with a poor prognosis and negative effects on quality of life. Educating patients and families plays an important role in its management, and caregivers sometimes forget that in select patients who are candidates for it, antineoplastic therapy can occasionally reverse some aspects of this syndrome. Patients may also benefit from appetite stimulants such as corticosteroids and progestational agents, and this review summarizes the benefits of using these agents as well as their contraindications.

Original languageEnglish (US)
Pages (from-to)499-502
Number of pages4
JournalJournal of Supportive Oncology
Volume4
Issue number10
StatePublished - Nov 1 2006

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach'. Together they form a unique fingerprint.

Cite this